Joint effort to target the orphan of the orphan

In this issue of Blood, Cuvelier and colleagues from the Applied Biomarkers of Late Effects of Childhood Cancer (ABLE) Consortium evaluate, for the first time, the performance of the National Institutes of Health Consensus Criteria (NIH-CC) for diagnosing chronic graft-versus-host disease (cGVHD) in pediatric patients in a prospective multicenter trial. They demonstrate the utility and limitations of the criteria and provide a benchmark for...